Reed Hastings invests in Olix
Funding Provisional 92% confidence first seen
Reed Hastings, Netflix cofounder, invested in Olix, a UK-based AI chip startup, as part of a $312 million Series B funding round that valued the company at $3.3 billion in 2024. The investment, alongside backing from Arm and the UK government's Sovereign AI fund, supports Olix's development of the DX-1 decode accelerator chip designed to compete with Nvidia by delivering faster and more cost-effective AI inference capabilities. The funding reflects confidence in Olix's technology to address bottlenecks in AI infrastructure, with the company targeting first customer deployments in 2025-2027.
The deal
Olix $312M Series B · announced 3 Aug 2026
Investors UK government Sovereign AI fund UK government's Sovereign AI fund Fundemo Sovereign AI Fund UK Sovereign AI fund Arm Reed Hastings
Deal terms as reported in the coverage below.
Decision brief
- What changed
- UK AI chip startup Olix closed a $312 million Series B round, reaching a $3.3 billion valuation just six months after hitting unicorn status, with backers including Netflix cofounder Reed Hastings, Arm, and the UK government's Sovereign AI fund. The funding will support development of Olix's DX-1 decode accelerator chip, aimed at delivering high-throughput, cost-effective AI inference as an alternative to Nvidia.
- Why it matters
- This signals growing investor appetite for Nvidia alternatives in AI inference hardware, which could affect compute-cost planning and supply-chain diversification strategy for companies dependent on GPU access. Sovereign fund and Arm involvement also suggests emerging government-backed competition in AI chip infrastructure that could reshape vendor options over the next few years.
- Evidence
- The claim is based on a single source, Trending Topics EU, reporting the funding round, valuation, and investor list; there is no independent corroboration from other outlets in the provided coverage.
- What remains uncertain
- Performance claims (10,000 tokens per second per user for 100B parameter models) are self-reported and unverified by independent benchmarks; it's unclear how the valuation tripled in six months or what specific commercial traction, if any, underlies it. Customer deployment is only projected for 2025-2027, so real-world viability remains unproven.
- Monitor next
- Watch for announcements of Olix's first customer deployments or independent benchmark testing of the DX-1 chip in 2025-2026.
Analytical support, not advice — assumptions and open questions stated above.